| A case of rabdomyolysis associated with simvastatin‐clopidogrel combination therapy |
|
Yong Soo Kwon, Seung Tai Kim, Pil Sang Song, Dong Ryeol Ryu, So Yeon Choi, Jin Young Lee, Duk-Kyung Kim |
|
Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea |
| 증례 : Simvastatin 복용 중인 환자에서 Clopidogrel 병합요법 후 발생한 횡문근 융해증 1예 |
|
권용수&#;김승태&#;송필상&#;류동열&#;최소연&#;이진영&#;김덕경, Seung Tai Kim, Pil Sang Song, Dong Ryeol Ryu, So Yeon Choi, Jin Young Lee, Duk-Kyung Kim |
|
|
|
|
|
|
| Abstract |
|
Simvastatin, the 3‐hydroxy‐3methylglutaryl coenzyme (HMG‐CoA) reductase inhibitor is effective in reduction the risk of coronary event and are generally well tolerated. Rhabdomyolysis is uncommon complication of this drug. We describe a case of rhabdomyolysis associated with concomitant use of simvastatin and clopidogrel. Rhabdomyolysis occurred 30 days after clopidogrel added to a chronic stable dose of simvastatin, and resolved after discontinuation of simvastatin and clopidogrel. We recommend careful monitoring when clopidogrel is given to patients receiving simvastatin.(Korean J Med 69:S906-S909, 2005) |
| Key Words:
Rhabdomyolysis, Clopidogrel, Simvastatin. |
|
PDF Links
Full text via DOI
Download Citation
